AVLN
Avalyn Pharma Inc.
Avalyn Pharma Inc. (AVLN) has 5 SEC Form 4 filings (17 transaction rows) in the rolling window, disclosed by 3 distinct insiders. Most recent filing: May 5, 2026.
Insiders have net bought $25.0M over the trailing 6 months. The largest single insider purchase in this window was $10.0M by 10% Owner Novo Holdings A/S on May 1, 2026.
- Industry:Medical - Pharmaceuticals
- CEO:Lyn Baranowski
- Employees:50
- HQ:Boston, MA, US
- IPO:2026-04-30
Insider Buying
$25.0M
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Unique Insiders
3
in the rolling window
Market Cap
$1.2B
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
Novo Holdings A/SFirst filing | 10% Owner | Purchase | 555,555 | $10.0M | May 5 | SEC ↗ |
Carroll JillFirst filing | Insider | Purchase | 277,778 | $5.0M | May 1 | SEC ↗ |
SR ONE CAPITAL MANAGEMENT, LLCFirst filing | Insider | Purchase | 555,555 | $10.0M | May 1 | SEC ↗ |
Related companies
Avalyn Pharma Inc. is in the Healthcare sector.